Siddaramaiah, DKS involved in Rs 417-cr scam: Yeddyurappa

Mangaluru, Feb 14: In a unique initiative, students of a government school in Dakshina Kannada have made a food stop in the campus to provide water and food to birds and squirrels.

The students have hung coconut shells on trees in the school premises with food and water in it for birds and squirrels.

Speaking about the same, the Principal of the school said: "Students are taking a lot of interest in the activity. Various types of birds visit the school campus, making the ambience very nice."

He added that he wants children to become socially and environmentally conscious. "The one area where children need to be given exposure is the protection of the environment, the upkeep of the campus and the greenery in and around their homes as well as in their schools."

Commenting on the recent initiative of the school's eco-club, he said, "Using this small idea, we can have a great beginning towards taking up bigger initiatives to take care of the environment."

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.